"The Company will make appropriate disclosure in compliance with the Listing Regulations as and when any such requirement arises," the company said in a filing.The clarification came regarding reports that Cipla promoters are looking to sell a part stake in the promoter shareholding to private equity investors.Cipla was up 9.62 per cent in trade on Thursday at Rs 1171 on BSE.Param Desai - Research Analyst, Prabhudas Lilladher said Cipla's Q1FY24 EBITDA was 13 per cent above our estimates, aided by higher GMs (64.3 per cent) and US sales of US$222mn."We continue to remain positive on growth across key segments including India and US given 1) strong traction in respiratory and other portfolio, 2) potential growth of +10 per cent in domestic formulations and 3) sustainability of current US revs, backed by prospective key launches over FY25," he said.--IANSsan/dpb(Disclaimer: This post has been auto published from IANS news agency without any modification to the text and has not been reviewed by editor)